Table 1.
Patient demographics
Characteristics | No. |
---|---|
Total number of patients | 52 |
KPS, range (median) | 70-100 (90) |
M:F | 30:22 |
Age, range (median) y | 19.5-62 (47.3) |
Diseases | |
AML CR1 | 9 |
Intermediate* | 6 |
High risk* | 3 |
AML CR2 | 7 |
AML CR1 after MDS | 5 |
ALL CR1 | 5 |
Ph+ | 3 |
Ph+, mono 7 | 1 |
t(9;17), mono 7 | 1 |
ALL CR2 | 1 |
ALL CR3 or greater | 1 |
AL, other | 3 |
CML CP1 | 4 |
CML, advanced | 2 |
MDS | 2 |
RA after AML | 1 |
RAEB-IT | 1 |
NHL | 11 |
B cell | |
Low | 1 |
Intermediate | 5 |
High | 4 |
T cell | 1 |
T-PLL | 2 |
Donors | |
M → F | 11 |
M → M | 16 |
F → M | 14 |
F → F | 11 |
Age, range (median), y | 14-71 (45) |
Grafts | |
PBSC | 47 |
BM | 4 |
Both | 1 |
CR indicates complete remission; AL, acute leukemia multilineage; CML, chronic myelogenous leukemia; CP, chronic phase; MDS, myelodysplastic syndrome; RA, refractory anemia; RAEB-IT, refractory anemia with excess blasts in transformation; and T-PLL, T-cell prolymphocytic leukemia.
By cytogenetics.